PRSS contributes to cetuximab resistance in colorectal cancer.
Tan Z, Gao L, Wang Y, Yin H, Xi Y, Wu X, Shao Y, Qiu W, Du P, Shen W, Fu L, Jia R, Zhao C, Zhang Y, Zhao Z, Sun Z, Chen H, Hu X, Xu J, Wang Y.
Tan Z, et al.
Sci Adv. 2020 Jan 1;6(1):eaax5576. doi: 10.1126/sciadv.aax5576. eCollection 2020 Jan.
Sci Adv. 2020.
PMID: 31911942
Free PMC article.